ArticleBlood cancer journal2025

Circulating tumor cells by Next Generation Flow Cytometry as a new prognostic biomarker for patients with asymptomatic monoclonal gammopathies.

Efstathios Kastritis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.